IMMUNIC, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • May 2nd, 2022 • Immunic, Inc. • Pharmaceutical preparations • New York
IMMUNIC, INC., a Delaware corporation (the “Company”), has previously entered into (i) a Sales Agreement with SVB Securities LLC (the “Agent”), dated as of July 17, 2019 (the “2019 Sales Agreement”), to issue and sell shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”) pursuant to a registration statement filed by the Company on Form S-3 on May 25, 2018, as amended on June 8, 2018 (File No. 333-225230) and (ii) a Sales Agreement with the Agent, dated as of December 29, 2020 (the “2020 Sales Agreement”), to issue and sell shares of Common Stock pursuant to a registration statement filed by the Company on Form S-3 on November 13, 2020 (File No. 333-250083), which 2020 Sales Agreement remains in full force and effect on the date hereof. The 2019 Sales Agreement is hereby terminated pursuant to Sections 11(b) and 11(c) thereof, effective immediately, with each of the Company and the Agent waiving the notice period contemplated thereby. The Company now c
